Smarmore Castle is a residential drug and alcohol rehabilitation clinic that treats alcoholism, drug and gambling addiction.
At Smarmore residential rehab clinic, we offer the clinical excellence and specialist treatment experience for which our founding clinic in Scotland is renowned. Our addiction treatment programme has been carefully constructed with over 30 years’ practical and professional experience. We treat addiction as a disease of the brain and evidence shows that abstinence is essential for a long-lasting recovery.
The treatment programme at Smarmore Castle Private Clinic is based on the highly successful addiction treatment model, pioneered by Castle Craig Hospital since 1988. Castle Craig has treated over 9,000 patients.
Independent research of former patients treated at Castle Craig shows that up to 73% achieve long-term abstinence following treatment, and up to 92% see an overall improvement. The programme developed by Castle Craig is one of the UK’s most established and respected and boasts very high client satisfaction rates, which we strive to match at Smarmore Castle.
Sometimes additional help is needed for a loved on to see the hurt they are causing themselves and the family
The role of an intervention professional is to help families understand their loved one’s addiction. They are not there to mediate a family therapy session.
An interventionist’s primary role is to help build the bridge to the family’s recovery while helping them better understand the person’s behaviours and their reaction to those behaviours.
An intervention specialist may work on their own or with another person. They will work with the families beforehand and carry out a thorough assessment of their needs. It’s important that they gain an accurate insight into what the dynamics are within the family, and whether their loved one is also suffering from any additional mental health issues such as depression, bipolar disorder or borderline personality disorder.
Call now: +353 41 214 5111 to arrange an intervention.
Page created: 25 February, 2020 Last updated and clinically assessed 10 January, 2022